Bank Of New York Mellon Corp Logic Bio Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.03 - $7.57 $173,564 - $326,024	-43,068 Reduced 79.76%	10,930 $48,000
Q1 2021 May 13, 2021	SELL	$6.8 - $9.16 $12,437 - $16,753	-1,829 Reduced 3.28%	53,998 $393,000
Q4 2020 Feb 09, 2021	BUY	$5.29 - $9.1 $140,888 - $242,360	26,633 Added 91.23%	55,827 $425,000
Q3 2020 Nov 12, 2020	BUY	$5.41 - $9.45 $1,292 - $2,258	239 Added 0.83%	29,194 $265,000
Q2 2020 Aug 12, 2020	BUY	$4.25 - $8.46 $34,437 - $68,551	8,103 Added 38.86%	28,955 $244,000
Q3 2019 Nov 07, 2019	SELL	$6.97 - $13.46 $13,152 - $25,399	-1,887 Reduced 8.3%	20,852 $225,000
Q2 2019 Aug 12, 2019	SELL	$9.77 - $17.08 $2,168 - $3,791	-222 Reduced 0.97%	22,739 $295,000
Q1 2019 May 14, 2019	BUY	$7.93 - $10.41 $182,080 - $239,024	22,961 New	22,961 $227,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.